l General Information |
Product Name | Uricase from Candida sp. |
General deion | Mice deficient in uricase develop uric acid nephropathy and diabetes insipidus which can be mitigated with recombinant uricase treatment. |
Synonym | Urate: oxygen oxoreductase |
Assay | ≥2 units/mg solid; recombinant, expressed in E. coli | CAS Number | 9002-12-4 |
Molecular Weight | mol wt 35 kDa by SDS-PAGE | MDL number | MFCD00082126 |
Suitability | BioReagent |
l Physical and Chemical Information |
Appearance | Off White to Light Yellow to Light Brown lyophilized powder |
Physical form | Powder; contains citrate and sucrose |
l Biological Information |
Biochem/Physiol Actions | Suitable for the determination of uric acid in clinical analysis. |
Unit Definition | One unit will oxidize 1.0 μmole of uric acid to allantoin per minute at pH 8.5 at 25 °C. |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
